Nexalin Technology Inc. is a healthcare technology company that designs and develops non-invasive neurostimulation medical devices focused on mental health. The company’s primary products are neurostimulation systems intended to help treat conditions such as anxiety, depression, and insomnia by delivering a proprietary electrical waveform to targeted areas of the brain without the use of drugs. Nexalin Technology Inc. positions its devices as easy-to-administer solutions for clinicians and treatment centers, aiming to integrate into existing mental health care workflows. Its flagship Generation 1 device is a cranial electrotherapy stimulation system classified as a Class II medical device by the U.S. Food and Drug Administration. Headquartered in Houston, Texas and founded in 2010, Nexalin Technology Inc. operates within the medical device segment of the healthcare sector, serving mental health providers seeking alternative or adjunctive approaches to conventional pharmacological and psychotherapeutic treatments.